List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 613 studies with search of: "Hyperlipidemias"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia
Conditions: Hyperlipidemia;   Hypercholesterolemia;   Hypertriglyceridemia
Intervention: Drug: ezetimibe (+) simvastatin
2 Completed Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
Conditions: Hyperlipidemia;   Mixed Hyperlipidemia;   Dyslipidemia
Intervention: Drug: Niacin Extended Release/Lovastatin
3 Completed Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia
Condition: Hyperlipidemia
Intervention: Drug: Nidadd
4 Completed To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia
Condition: Hyperlipidemias
Intervention:
5 Active, not recruiting A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia
Condition: Combined Hyperlipidemia
Interventions: Drug: Pravastatin;   Drug: Fenofibrate;   Drug: Pravafen (Combination of Pravastatin and Fenofibrate)
6 Not yet recruiting Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Patients With Mixed Hyperlipidemia and Two or More Risk Factors to Cardiovascular Disease.
Conditions: Cardiovascular Diseases;   Hyperlipidemia
Interventions: Drug: Placebo (unspecified);   Drug: ezetimibe (+) simvastatin (Vytorin);   Drug: niacin (+) laropiprant (MK0524A)
7 Recruiting Compliance With Treatment For Patients With Hyperlipidemia
Condition: Hyperlipidemia
Intervention: Device: Lipid Self Test
8 Recruiting A Comparison of SLx-4090 in Combination With Statin Therapy Versus Statin Therapy Alone in Reducing LDL-C in Patients With Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: SLx-4090;   Drug: SLx-4090;   Other: Placebo
9 Completed Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia
Conditions: Hyperlipidemia;   HIV Infections
Intervention: Drug: Atazanavir
10 Completed Effect of TAK-475 Combined With Fenofibrate on Blood Cholesterol Levels
Condition: Hyperlipidemias
Interventions: Drug: TAK-475 and fenofibrate;   Drug: Fenofibrate
11 Not yet recruiting Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy
Conditions: HIV;   Hyperlipidemia;   Hypertriglyceridemia
Intervention: Drug: raltegravir
12 Not yet recruiting Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-Infected Patients
Conditions: HIV;   Hyperlipidemia;   HIV Infections
Interventions: Drug: ezetimibe;   Drug: fenofibrate;   Drug: pravastatin
13 Recruiting Lipid Efficacy and Safety in Patients With Mixed Hyperlipidemia
Condition: Mixed Hyperlipemia
Interventions: Drug: MK0524B;   Drug: Atorvastatin
14 Completed An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)
Conditions: Hyperlipidemia;   Mixed Dyslipidemia
Interventions: Drug: Niacin ER/Simvastatin Tablets;   Drug: atorvastatin
15 Completed Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia
Condition: Type II Hyperlipidaemia
Interventions: Drug: Placebo;   Drug: JTT-705 300mg;   Drug: JTT-705 600mg;   Drug: JTT-705 900mg
16 Completed Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia
Condition: Type II Hyperlipidemia
Interventions: Drug: JTT-705 600 mg and pravastatin 40 mg;   Drug: JTT-705 300 mg and pravastatin 40 mg;   Drug: Placebo and pravastatin 40 mg
17 Recruiting Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes
Conditions: Postprandial Lipemia;   Type 2 Diabetes
Interventions: Drug: ezetimibe tablets;   Drug: simvastatin tablets;   Drug: placebo
18 Completed Effects of Dietary Proteins on Postprandial Lipaemia and Incretin Responses in Obese Subjects
Conditions: Postprandial Lipaemia;   Postprandial Incretins;   Postprandial Inflammation
Interventions: Dietary Supplement: Casein;   Dietary Supplement: Whey Isolate;   Dietary Supplement: Whey Hydrolysate;   Dietary Supplement: Alphalact-Albumin
19 Recruiting Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects
Conditions: Obesity;   Postprandial Lipemia;   Atherosclerosis;   Inflammation;   Postprandial Incretins
Interventions: Dietary Supplement: Caseine;   Dietary Supplement: Cod;   Dietary Supplement: Gluten;   Dietary Supplement: Whey Isolate
20 Completed Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol
Conditions: Hypercholesterolemia;   Hyperlipidemia, Familial Combined
Interventions: Drug: colesevelam HCl tablets and fenofibrate tablets;   Drug: fenofibrate tablets and Welchol placebo tablets;   Drug: fenofibrate tablets and Welchol placebo tablets

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services